Trial Profile
ONO-2745 Open-label Study Multi-center, double-blind, randomized, parallel-group study in patients undergoing surgery requiring general anesthesia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications General anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 27 May 2016 New trial record